No Detail Found!

The partial virological response to Tenofovir monotherapy in naïve patients with chronic hepatitis B

Author(s)
Habip Gedik Department of Infectious Disease and Clinical Microbiology, University of Health Sciences and Ministry of Health, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
Muge Sonmezisik Department of Infectious Disease and Clinical Microbiology, University of Health Sciences and Ministry of Health, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
Abstract
We report two treatment-naïve cases, a 26-year-old female patient and a 59-year-old male patient who were followed up for chronic hepatitis B (CHB) at the department of Infectious Diseases and Clinical microbiology. A partial response subsequent to 12 months of Tenofovir Disoproksil (TDF) monotherapy presumably due to an antiviral-drug resistance was noted. A sustained viral response with TDF (245 mg) or Tenofovir Alafenamide (TAF, 25 mg) + Entecavir (ETV, 1 mg) combination therapy was observed after failure with TDF monotherapy. A combination therapy with TDF (245 mg) or TAF (25 mg) +ETV (1 mg) is efficacious in naïve patients with a partial response to TDF monotherapy.
Publication Details
Page(s) 550-552
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 71, Issue: 2A, Year: 2021

Request the full text from PASTIC

Keywords
Entecavir, Combination therapy, Chronic hepatitis B, Tenofovir, partial response
0

Citations

0

Downloads

78

Views